|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,562.00 KRW | -5.90% |
|
-8.28% | -32.09% |
| 05-14 | SCL Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 03-23 | SCL Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 53.13B 36.52M 32.05M 29.84M 27.45M 51.45M 3.49B 52.34M 354M 139M 1.73B 137M 134M 5.98B | P/E 2024 |
-16x | P/E 2025 | -19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 75.66B 52M 45.64M 42.5M 39.09M 73.27M 4.97B 74.53M 504M 197M 2.46B 195M 191M 8.51B | EV / Sales 2024 |
13.3x | EV / Sales 2025 | 4.57x |
| Free-Float |
45.72% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -5.90% | ||
| 1 week | -8.28% | ||
| Current month | -7.02% | ||
| 1 month | +0.39% | ||
| 3 months | -25.26% | ||
| 6 months | -32.09% | ||
| Current year | -32.09% |
| 1 week | 1,558 |  | 1,738 |
| 1 month | 1,558 | | 1,946 |
| Current year | 1,504 | | 2,680 |
| 1 year | 1,504 | | 3,250 |
| 3 years | 1,504 | | 5,110 |
| 5 years | 1,504 | | 5,110 |
| 10 years | 1,300 | | 6,950 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kyung-Yul Lee
CEO | Chief Executive Officer | - | 2022-12-27 |
Se-Yeon Baek
CEO | Chief Executive Officer | 59 | 2024-09-29 |
Dae-Young Kim
AUD | Comptroller/Controller/Auditor | 63 | 2022-12-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Se-Yeon Baek
BRD | Director/Board Member | 59 | 2024-09-29 |
Jeong-Gyun Choi
BRD | Director/Board Member | 59 | 2024-09-29 |
Kyung-Yul Lee
BRD | Director/Board Member | - | 2022-12-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/11/25 | Free | 1,359 | 0.0040% | |||
| 8/11/25 | Free | 13,650 | 0.0402% | |||
| 8/11/25 | Free | 12,582 | 0.0371% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.90% | -8.28% | -39.92% | -22.29% | 38.45M | |
| +4.20% | +2.96% | +24.44% | -6.82% | 67.88B | |
| +1.79% | +2.58% | +39.89% | +213.85% | 53.23B | |
| +0.26% | +54.90% | +54.90% | +54.90% | 48.71B | |
| +6.49% | +7.87% | -53.23% | -52.62% | 38.98B | |
| +2.73% | +1.21% | +59.04% | -22.48% | 29.55B | |
| +9.30% | +10.68% | +85.19% | +105.94% | 23.75B | |
| +0.31% | -6.46% | +64.57% | -52.97% | 22.07B | |
| -0.33% | -3.25% | -10.71% | +157.95% | 19.84B | |
| +0.60% | +0.39% | +65.65% | +126.60% | 16.57B | |
| Average | +1.90% | +0.93% | +28.98% | +50.21% | 32.06B | |
| Weighted average by Cap. | +2.96% | +2.66% | +32.59% | +54.44% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.74B 3.26M 2.86M 2.66M 2.45M 4.59M 311M 4.67M 31.57M 12.36M 154M 12.22M 11.96M 533M | 22.01B 15.13M 13.28M 12.36M 11.37M 21.32M 1.45B 21.68M 147M 57.41M 717M 56.79M 55.57M 2.48B |
| Net income | -3.73B -2.56M -2.25M -2.1M -1.93M -3.61M -245M -3.67M -24.86M -9.73M -121M -9.62M -9.42M -420M | -3.93B -2.7M -2.37M -2.21M -2.03M -3.81M -258M -3.88M -26.22M -10.26M -128M -10.15M -9.93M -443M |
| Net Debt | 3.15B 2.16M 1.9M 1.77M 1.62M 3.05M 207M 3.1M 20.96M 8.2M 102M 8.12M 7.94M 354M | 22.53B 15.49M 13.59M 12.66M 11.64M 21.82M 1.48B 22.2M 150M 58.77M 734M 58.14M 56.88M 2.54B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-28 | ₩1,562.00 | -5.90% | 49,109 |
| 26-07-27 | ₩1,660.00 | 0.00% | 29,842 |
| 26-07-24 | ₩1,660.00 | +0.18% | 11,914 |
| 26-07-23 | ₩1,657.00 | -0.66% | 51,784 |
| 26-07-22 | ₩1,668.00 | -2.06% | 34,940 |
- Stock Market
- Stocks
- A246960 Stock
Select your edition
All financial news and data tailored to specific country editions
